Weekly reads: cartilage regeneration, ferroptosis, Aspen Neuroscience raises $115M, more on rare diseases
Professor Paul Knoepfler, Ph.D.
Cartilage regeneration has been a holy grail for the stem cell field for decades. It has mostly been just out of reach though. Even most unproven stem cell clinics have stopped claiming to regrow cartilage in joints. For instance, a typical clinic that now injects PRP or cells into arthritic knees doesn’t claim to regrow […] The post Weekly reads: cartilage regeneration, ferroptosis, Aspen Neuroscience raises $115M, more on rare diseases appeared first on The Niche .